サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1401388

グライコミクスの世界市場規模調査＆予測、製品別、用途別、最終用途別、地域別分析、2023～2030年

Global Glycomics Market Size study & Forecast, by Product, by Application, by End-Use and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
グライコミクスの世界市場規模調査＆予測、製品別、用途別、最終用途別、地域別分析、2023～2030年
出版日: 2023年11月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のグライコミクス市場は2022年に約16億5,000万米ドルと評価され、予測期間2023～2030年には14.6%以上の健全な成長率で成長すると予測されています。

グライコミクスとは、すべての生物に存在する糖鎖である糖鎖の研究です。この分野は、糖鎖の構造、生物学的性質、機能を理解することに重点を置いており、疾患プロファイリングや生物学的プロセスにおいて関心を集めています。しかし、グライコミクス研究で使用されるツールのコストが高いことが市場成長の妨げとなっています。

グライコミクス機器の技術的進歩は、政府やバイオテクノロジー企業による投資の増加とともに、世界市場を牽引する主要要因となっています。例えば、2020年7月、GlycoNet社は、グライコミクス研究の研究努力を支援するために1,630万米ドルの資金提供を受けた。さらに、疾患プロファイリングや生物学的プロセスにおけるグライコミクスの研究がますます盛んになり、この分野の研究開発活動が大幅に増加しています。最近では、2021年4月にCanadian Glycomics NetworkとBridgeBio Pharma, Inc.が提携し、グライコミクスの科学的研究を遺伝性疾患患者の治療法開発に応用しようとしています。しかし、糖鎖は複雑で多様であるため、その分析と特性解析は市場の推進にとって困難なものとなっています。このような課題にもかかわらず、バイオテクノロジー企業やバイオ製薬企業の数は増加しており、グライコミクス市場にビジネスチャンスをもたらす可能性があります。

世界のグライコミクス市場の調査で考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカが含まれます。北米は、研究開発活動と政府助成プログラムの増加により、2022年の市場を独占しました。企業は研究開発活動に投資しており、同地域のグライコミクスの成長を促進すると期待されています。Statista社のレポートによると、2022年、一部の製薬企業による研究開発（R&D）支出は世界で約1,010億米ドルに達しました。欧州は予測期間中に大きく成長すると予想されています。世界トップクラスの大学や研究機関が存在する研究インフラなどの要因によるものです。また、研究のための資金提供プログラムや助成金が利用できるため、バイオ製薬企業や学術機関はこの地域でより広範なグライコミクス研究を実施できるようになっています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のグライコミクス市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界のグライコミクス市場力学

  • グライコミクス市場の影響分析（2020～2030年）
    • 市場の促進要因
      • 疾患プロファイリングや生物学的プロセスにおけるグライコミクスの役割解明への関心の高まり
      • グライコミクス機器への技術投資
    • 市場の課題
      • ツールの高コスト
      • 糖鎖の複雑さ
    • 市場機会
      • 企業や政府による研究開発投資の増加
      • バイオテクノロジーとバイオ医薬品産業の増加

第4章 世界のグライコミクス市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主要投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 グライコミクスの世界市場：製品別

  • 市場スナップショット
  • グライコミクスの世界市場：製品別、実績・ポテンシャル分析
  • グライコミクスの世界市場：製品別、推定・予測、2020～2030年
  • グライコミクス市場、サブセグメント分析
    • 酵素
    • キット
    • 試薬
    • 器具

第6章 グライコミクスの世界市場：用途別

  • 市場スナップショット
  • グライコミクスの世界市場：用途別、実績・ポテンシャル分析
  • グライコミクスの世界市場、用途別、推定・予測、2020～2030年
  • グライコミクス市場、サブセグメント分析
    • 創薬・医薬品開発
    • 診断薬
    • その他

第7章 グライコミクスの世界市場：エンドユーザー別

  • 市場スナップショット
  • グライコミクスの世界市場：最終用途別、実績・ポテンシャル分析
  • グライコミクスの世界市場、最終用途別、推定・予測、2020～2030年
  • グライコミクス市場、サブセグメント分析
    • 学術・研究機関
    • 製薬・バイオテクノロジー企業
    • バイオ医薬品企業
    • CRO（医薬品開発業務受託機関）

第8章 グライコミクスの世界市場：地域別分析

  • 主要国
  • 主要新興国
  • グライコミクスの世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品、推定・予測、2020～2030年
      • 用途、推定・予測、2020～2030年
      • 最終用途、推定・予測、2020～2030年
    • カナダ
  • 欧州のグライコミクス市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋のグライコミクス市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカのグライコミクス市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
    • Merck KgaA
    • Agilent Technologies Inc.
    • Bruker
    • New England Biolabs
    • Shimadzu Corporation
    • Waters Corporation
    • Takara Bio Inc
    • Asparia Glycomics
    • RayBiotech Life, Inc.

第10章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Glycomics Market, report scope
  • TABLE 2. Global Glycomics Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Glycomics Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Glycomics Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Glycomics Market estimates & forecasts by End-Use 2020-2030 (USD Billion)
  • TABLE 6. Global Glycomics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Glycomics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Glycomics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Glycomics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Glycomics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Glycomics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Glycomics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Glycomics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Glycomics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Glycomics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Glycomics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Glycomics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Glycomics Market
  • TABLE 71. List of primary sources, used in the study of global Glycomics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Glycomics Market, research methodology
  • FIG 2. Global Glycomics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Glycomics Market, key trends 2022
  • FIG 5. Global Glycomics Market, growth prospects 2023-2030
  • FIG 6. Global Glycomics Market, porters 5 force model
  • FIG 7. Global Glycomics Market, pest analysis
  • FIG 8. Global Glycomics Market, value chain analysis
  • FIG 9. Global Glycomics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Glycomics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Glycomics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Glycomics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Glycomics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Glycomics Market, regional snapshot 2020 & 2030
  • FIG 15. North America Glycomics Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Glycomics Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Glycomics Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Glycomics Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Glycomics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Glycomics Market is valued at approximately USD 1.65 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.6% over the forecast period 2023-2030. Glycomics is the study of glycans, which are saccharides found in all living organisms. The field is focused on understanding their structure, biology, and function, and has gained interest in disease profiling and biological processes. However, the high cost of tools used in glycomics research hinder market growth.

Technological advancements in glycomics instruments have been a major factor driving the global market, along with increasing investments from governments and biotech companies. For example, in July 2020, GlycoNet, received funding of USD 16.3 million to support their research efforts in glycomic research. Moreover, the study of glycomics in disease profiling and biological processes has become increasingly popular, leading to a significant increase in research and development activities in this area. Recently, the Canadian Glycomics Network and BridgeBio Pharma, Inc. joined forces in April 2021 to apply scientific research in glycomics to develop treatments for patients with genetic diseases. However, the complexity and diversity of glycans make their analysis and characterization challenging for the market to propel. Despite all the challenges, the growing number of biotechnology and biopharmaceutical companies can offer opportunities in the glycomics market.

The key regions considered for the Global Glycomics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to increasing research and development activities and government funding programs. Companies are investing in research and development activities, which are expected to propel the growth of glycomics in the region. According to a report by Statista, in 2022, the research and development (R&D) expenditure by some pharmaceutical companies reached around 101 billion U.S. dollars worldwide. Europe is expected to grow significantly over the forecast period. Due to factors such as research infrastructure with the presence of world-class universities and research institutes. In addition, the availability of funding programs and grants for research has allowed biopharmaceutical companies and academic institutions to conduct more extensive glycomics studies in this region.

Major market player included in this report are:

  • Thermo Fisher Scientific, Inc.
  • Merck KgaA
  • Agilent Technologies Inc.
  • Bruker
  • New England Biolabs
  • Shimadzu Corporation
  • Waters Corporation
  • Takara Bio Inc
  • Asparia Glycomics
  • RayBiotech Life, Inc.

Recent Developments in the Market:

  • In September 2021, a team of researchers at the University of California San Diego created a new tool called GlyCompare which allows for the analysis of glycomics datasets using AI and other machine learning techniques. This approach takes into account the shared biosynthetic pathways of glycans in samples, making it a systems-level perception. The ultimate goal of this research is to contribute to the development of breakthroughs in cancer diagnostics.
  • In April 2021, BridgeBio Pharma, Inc. and the Canadian Glycomics Network collaborated to translate scientific research in glycomics into potential treatments for patients having genetic diseases.

Global Glycomics Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Application, End-Use, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Enzymes
  • Kits
  • Reagents
  • Instruments

By Application:

  • Drug Discovery & Development
  • Diagnostics
  • Others

By End-Use:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Biopharmaceutical Companies
  • CROs

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Glycomics Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Glycomics Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Glycomics Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Glycomics Market, by End-Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Glycomics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Glycomics Market Dynamics

  • 3.1. Glycomics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing interest in understanding the role of glycomics in disease profiling and biological processes
      • 3.1.1.2. Technological investment in glycomics instruments
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of the Tools
      • 3.1.2.2. Complexity of glycans
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising investments in research and development by companies and government
      • 3.1.3.2. Growing number of biotechnology and biopharmaceuticals industry

Chapter 4. Global Glycomics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Glycomics Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Glycomics Market by Product, Performance - Potential Analysis
  • 5.3. Global Glycomics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Glycomics Market, Sub Segment Analysis
    • 5.4.1. Enzymes
    • 5.4.2. Kits
    • 5.4.3. Reagents
    • 5.4.4. Instruments

Chapter 6. Global Glycomics Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Glycomics Market by Application, Performance - Potential Analysis
  • 6.3. Global Glycomics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Glycomics Market, Sub Segment Analysis
    • 6.4.1. Drug Discovery & Development
    • 6.4.2. Diagnostics
    • 6.4.3. Others

Chapter 7. Global Glycomics Market, by End-Use

  • 7.1. Market Snapshot
  • 7.2. Global Glycomics Market by End-Use, Performance - Potential Analysis
  • 7.3. Global Glycomics Market Estimates & Forecasts by End-Use 2020-2030 (USD Billion)
  • 7.4. Glycomics Market, Sub Segment Analysis
    • 7.4.1. Academic & Research Institutes
    • 7.4.2. Pharmaceutical & Biotechnology Companies
    • 7.4.3. Biopharmaceutical Companies
    • 7.4.4. CROs

Chapter 8. Global Glycomics Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Glycomics Market, Regional Market Snapshot
  • 8.4. North America Glycomics Market
    • 8.4.1. U.S. Glycomics Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End-Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Glycomics Market
  • 8.5. Europe Glycomics Market Snapshot
    • 8.5.1. U.K. Glycomics Market
    • 8.5.2. Germany Glycomics Market
    • 8.5.3. France Glycomics Market
    • 8.5.4. Spain Glycomics Market
    • 8.5.5. Italy Glycomics Market
    • 8.5.6. Rest of Europe Glycomics Market
  • 8.6. Asia-Pacific Glycomics Market Snapshot
    • 8.6.1. China Glycomics Market
    • 8.6.2. India Glycomics Market
    • 8.6.3. Japan Glycomics Market
    • 8.6.4. Australia Glycomics Market
    • 8.6.5. South Korea Glycomics Market
    • 8.6.6. Rest of Asia Pacific Glycomics Market
  • 8.7. Latin America Glycomics Market Snapshot
    • 8.7.1. Brazil Glycomics Market
    • 8.7.2. Mexico Glycomics Market
  • 8.8. Middle East & Africa Glycomics Market
    • 8.8.1. Saudi Arabia Glycomics Market
    • 8.8.2. South Africa Glycomics Market
    • 8.8.3. Rest of Middle East & Africa Glycomics Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Thermo Fisher Scientific, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Merck KgaA
    • 9.3.3. Agilent Technologies Inc.
    • 9.3.4. Bruker
    • 9.3.5. New England Biolabs
    • 9.3.6. Shimadzu Corporation
    • 9.3.7. Waters Corporation
    • 9.3.8. Takara Bio Inc
    • 9.3.9. Asparia Glycomics
    • 9.3.10. RayBiotech Life, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption